SLC30A8
SLC30A8, also known as ZnT-8 or ZNT8, is a proton-coupled zinc antiporter that moves zinc into the lumen of pancreatic beta cell secretory granules. In doing so it regulates insulin secretion. Browse Assay Genie's current range of SLC30A8 research reagents below, or read on for the biology behind the target.
SLC30A8 (solute carrier family 30 member 8) is a proton-coupled zinc ion antiporter. It mediates the entry of zinc into the lumen of pancreatic beta cell secretory granules, and through this activity it regulates insulin secretion. NCBI describes the protein as a zinc efflux transporter involved in the accumulation of zinc in intracellular vesicles, meaning it moves zinc out of the cytoplasm and into vesicular compartments.
The SLC30A8 gene encodes a member of the cation diffusion facilitator (CDF) transporter family (TC 2.A.4), in the SLC30A subfamily, and HGNC places it in the solute carrier family 30 gene group. Expression is reported at a high level only in the pancreas, particularly in the islets of Langerhans. In the insulin-secreting INS-1 cell line, the protein colocalises with insulin in secretory pathway granules. UniProt lists its locations as the secretory vesicle membrane and the cell membrane. Mouse and rat both carry an orthologous gene, Slc30a8. Several transcript variants encoding different isoforms have been described.
The protein is also known as ZnT-8 or ZNT8, and the gene was previously named solute carrier family 30 (zinc transporter), member 8. Allelic variants of the SLC30A8 gene confer susceptibility to non-insulin-dependent diabetes mellitus (NIDDM), which makes the transporter a focus for studies of islet zinc handling, insulin granule biology and the genetics of type 2 diabetes.
SLC30A8 loads zinc into beta cell secretory granules and regulates insulin secretion, making it central to studies of granule function.
Allelic variants of the SLC30A8 gene confer susceptibility to non-insulin-dependent diabetes mellitus, so it features in genetic and mechanistic diabetes research.
As a CDF family zinc efflux transporter, SLC30A8 supports work on how zinc accumulates in intracellular vesicles.
Expression is high in the pancreas, particularly the islets of Langerhans, so SLC30A8 is relevant to profiling islet and beta cell biology.
SLC30A8 is a proton-coupled zinc antiporter that mediates zinc entry into the lumen of pancreatic beta cell secretory granules. By doing so it regulates insulin secretion. NCBI describes it as a zinc efflux transporter that accumulates zinc in intracellular vesicles.
SLC30A8 is also called ZnT-8 or ZNT8, and its earlier name was solute carrier family 30 (zinc transporter), member 8. UniProt names the protein proton-coupled zinc antiporter SLC30A8. Several transcript variants encoding different isoforms have been reported for the gene.
Allelic variants of the SLC30A8 gene confer susceptibility to non-insulin-dependent diabetes mellitus. Orthologues named Slc30a8 exist in mouse and rat, so rodent models are used to study it. Check the datasheet of any product for its validated reactivity.
Other solute carrier family members, vesicular transporters and membrane transport targets with products at Assay Genie.
Gene and protein annotations from HGNC, NCBI Gene and UniProt Q8IWU4; product specifications from Assay Genie datasheets.